Session » Systemic Lupus Erythematosus – Clinical Aspects and Treatment II: Clinical Trial Design
-
Abstract Number: 1047
Negative Results of Antinuclear Antibody (ANA) Testing in Clinical Trials of Systemic Lupus Erythematosus (SLE) May be Due to Assay Variability
-
Abstract Number: 1048
Differences in Clinical Manifestations of SLE Across Four Racial/Ethnic Groups: The California Lupus Surveillance Project (CLSP)
-
Abstract Number: 1049
High Titer ANA Not Necessarily a Valid Criterion for Lupus – Proposal of a Modification to the Criteria for Classification of SLE
-
Abstract Number: 1050
Defining Low Disease Activity in Systemic Lupus Erythematosus